Key Takeaways
WuXi AppTec (2359.HK) plans to raise approximately $1.023 billion through a RMB 6.78 billion zero-coupon convertible bond sale due in 2027.
The proposed issuance was detailed in a company announcement on Thursday, outlining the terms and strategic use of proceeds.
The bonds carry an initial conversion price of HKD 153 per H-share, a 17.6 percent premium over the May 14 closing price of HKD 130.1. If fully converted, the bonds would create approximately 51.147 million new H-shares, equal to 9.11 percent of the enlarged H-share capital and 1.69 percent of the total enlarged share capital. According to a term sheet seen by Reuters, the bonds were offered with a yield to maturity between minus 3.0 and minus 3.5 percent.
The capital raise is aimed at accelerating the company's global expansion, with about 90 percent of the net proceeds earmarked for enhancing capacity and capabilities worldwide. While the move signals confidence in long-term growth, investors will weigh the expansion plans against the risk of future share dilution.
The negative yield-to-maturity suggests strong investor demand for exposure to the company's equity through the convertible structure. The successful placement of this bond will be a key indicator of market appetite for growth-oriented Chinese healthcare names. Investors will now watch the stock's performance relative to the HKD 153 conversion price.
This article is for informational purposes only and does not constitute investment advice.
